Tauxib may be available in the countries listed below.
Ingredient matches for Tauxib
Etoricoxib is reported as an ingredient of Tauxib in the following countries:
- Italy
International Drug Name Search
Tauxib may be available in the countries listed below.
Etoricoxib is reported as an ingredient of Tauxib in the following countries:
International Drug Name Search
Clindamycin-CT may be available in the countries listed below.
Clindamycin hydrochloride (a derivative of Clindamycin) is reported as an ingredient of Clindamycin-CT in the following countries:
International Drug Name Search
Osanit may be available in the countries listed below.
Calcitonin is reported as an ingredient of Osanit in the following countries:
International Drug Name Search
Estrogen, alone or in combination with progestin hormones, should not be used to prevent heart disease or dementia. Estrogen taken alone or in combination with progestin may increase the risk of heart disease (including heart attacks), stroke, serious blood clots in the lung (pulmonary embolism) or leg (deep venous thrombosis), breast cancer, or dementia. These risks appear to depend on the length of time Drospirenone/Estradiol is used and the amount of estrogen per dose. Therefore, Drospirenone/Estradiol should be used for the shortest possible length of time at the lowest effective dose so you obtain the benefits and minimize the chance of serious side effects from long-term treatment. Discuss any questions or concerns with your doctor.
Treating certain moderate to severe symptoms of menopause (eg, hot flashes; dryness, itching, and burning in or around the vagina). It may also be used for other conditions as determined by your doctor.
Drospirenone/Estradiol is a combination of progestin and estrogen hormones. It works by replacing natural progestin and estrogen in women who can no longer produce enough of these hormones.
Contact your doctor or health care provider right away if any of these apply to you.
Some medical conditions may interact with Drospirenone/Estradiol. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:
Some MEDICINES MAY INTERACT with Drospirenone/Estradiol. Tell your health care provider if you are taking any other medicines, especially any of the following:
This may not be a complete list of all interactions that may occur. Ask your health care provider if Drospirenone/Estradiol may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.
Use Drospirenone/Estradiol as directed by your doctor. Check the label on the medicine for exact dosing instructions.
Ask your health care provider any questions you may have about how to use Drospirenone/Estradiol.
All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:
Back pain; breast tenderness, pain, or enlargement; headache; mild hair loss; nausea; nervousness; stomach cramps, bloating, or pain; vaginal spotting or breakthrough bleeding; vomiting; weight changes.
Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue; unusual hoarseness); calf pain, swelling, or tenderness; chest pain; confusion; discharge from the nipples; fainting; irregular heartbeat; lumps in the breast; mental or mood changes (eg, depression, irritability, memory loss); numbness of an arm or leg; one-sided weakness; severe or persistent dizziness or stomach pain; severe or persistent breast pain; severe, persistent, or recurring abnormal vaginal bleeding; speech changes (eg, slurred speech); sudden severe headache, nausea, or vomiting; sudden shortness of breath; sudden weight gain; swelling of the hands or feet; unusual vaginal discharge, itching, or odor; vision changes (eg, double vision, sudden vision loss); yellowing of the skin or eyes.
This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.
See also: Drospirenone/Estradiol side effects (in more detail)
Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include severe or persistent nausea; severe or unusual vaginal bleeding.
Store Drospirenone/Estradiol at room temperature, between 68 and 77 degrees F (20 and 20 degrees C). Brief storage at temperatures between 59 and 86 degrees F (15 and 30 degrees C) is permitted. Store away from heat, moisture, and light. Do not store in the bathroom. Keep Drospirenone/Estradiol out of the reach of children and away from pets.
This information is a summary only. It does not contain all information about Drospirenone/Estradiol. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.
AteNif beta may be available in the countries listed below.
Atenolol is reported as an ingredient of AteNif beta in the following countries:
Nifedipine is reported as an ingredient of AteNif beta in the following countries:
International Drug Name Search
Calcio Carbonato + Vitamina D3 ABC may be available in the countries listed below.
Calcium Carbonate is reported as an ingredient of Calcio Carbonato + Vitamina D3 ABC in the following countries:
Colecalciferol is reported as an ingredient of Calcio Carbonato + Vitamina D3 ABC in the following countries:
International Drug Name Search
Omaceph may be available in the countries listed below.
Cefalexin is reported as an ingredient of Omaceph in the following countries:
International Drug Name Search
Ceftazidim Stragen may be available in the countries listed below.
Ceftazidime pentahydrate (a derivative of Ceftazidime) is reported as an ingredient of Ceftazidim Stragen in the following countries:
International Drug Name Search
Mimedran may be available in the countries listed below.
Sultosilic Acid piperazine salt (a derivative of Sultosilic Acid) is reported as an ingredient of Mimedran in the following countries:
International Drug Name Search
Mebolin may be available in the countries listed below.
Mebhydrolin napadisilate (a derivative of Mebhydrolin) is reported as an ingredient of Mebolin in the following countries:
International Drug Name Search